BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12715412)

  • 1. Identification and management of oral isotretinoin use inconsistent with product labeling.
    Wert S
    Manag Care Interface; 2003 Mar; 16(3):41-3, 55. PubMed ID: 12715412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conducting research using pharmacy databases.
    Penna P
    Manag Care Interface; 2003 Mar; 16(3):31-2. PubMed ID: 12715410
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents.
    Kaymak Y; Taner E; Taner Y
    Int J Dermatol; 2009 Jan; 48(1):41-6. PubMed ID: 19126049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An expert view on the treatment of acne with systemic antibiotics and/or oral isotretinoin in the light of the new European recommendations.
    Dréno B; Bettoli V; Ochsendorf F; Perez-Lopez M; Mobacken H; Degreef H; Layton A
    Eur J Dermatol; 2006; 16(5):565-71. PubMed ID: 17101480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect of a moisturizing cream as adjunctive treatment to oral isotretinoin or topical tretinoin in the management of acne.
    Laquieze S; Czernielewski J; Rueda MJ
    J Drugs Dermatol; 2006; 5(10):985-90. PubMed ID: 17373148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No association found between patients receiving isotretinoin for acne and the development of depression in a Canadian prospective cohort.
    Cohen J; Adams S; Patten S
    Can J Clin Pharmacol; 2007; 14(2):e227-33. PubMed ID: 17556790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isotretinoin therapy for acne: a population-based study.
    Hogan DJ; Strand LM; Lane PR
    CMAJ; 1988 Jan; 138(1):47-50. PubMed ID: 2961430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris.
    Sardana K; Garg VK; Sehgal VN; Mahajan S; Bhushan P
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):556-60. PubMed ID: 19143903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral isotretinoin for acne, adjusting treatment according to patient's response.
    Ghaffarpour G; Mazloomi S; Soltani-Arabshahi R; Seyed KS
    J Drugs Dermatol; 2006 Oct; 5(9):878-82. PubMed ID: 17039654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral isotretinoin: an analysis of its utilization in a managed care organization.
    Chen K; White TJ; Juzba M; Chang E
    J Manag Care Pharm; 2002; 8(4):272-7. PubMed ID: 14613420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of an infantile acne with oral isotretinoin.
    Sarazin F; Dompmartin A; Nivot S; Letessier D; Leroy D
    Eur J Dermatol; 2004; 14(1):71-2. PubMed ID: 14965803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of acne by isotretinoin (general course)].
    Chivot M
    Rev Prat; 2002 Apr; 52(8):845-9. PubMed ID: 12053792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART program.
    Brinker A; Kornegay C; Nourjah P
    Arch Dermatol; 2005 May; 141(5):563-9. PubMed ID: 15897377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the European Directive for prescribing systemic isotretinoin for acne vulgaris.
    Layton AM; Dreno B; Gollnick HP; Zouboulis CC
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):773-6. PubMed ID: 16898895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An observational study of isotretinoin recipients treated for acne in a health maintenance organization.
    McElwee NE; Schumacher MC; Johnson SC; Weir TW; Greene SL; Scotvold MJ; Hunter JR; Dinan BJ; Jick H
    Arch Dermatol; 1991 Mar; 127(3):341-6. PubMed ID: 1825596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A practical approach for the use of oral isotretinoin for infantile acne.
    Barnes CJ; Eichenfield LF; Lee J; Cunningham BB
    Pediatr Dermatol; 2005; 22(2):166-9. PubMed ID: 15804310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term oral isotretinoin therapy does not cause clinical or subclinical peripheral neuropathy.
    Chroni E; Pasmatzi E; Monastirli A; Georgiou S; Katsoulas G; Polychronopoulos P; Tsambaos D
    J Dermatolog Treat; 2006; 17(1):6-8. PubMed ID: 16467017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris.
    Zane LT; Leyden WA; Marqueling AL; Manos MM
    Arch Dermatol; 2006 Aug; 142(8):1016-22. PubMed ID: 16924051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapse of acne following isotretinoin treatment: a retrospective study of 405 patients.
    Liu A; Yang DJ; Gerhardstein PC; Hsu S
    J Drugs Dermatol; 2008 Oct; 7(10):963-6. PubMed ID: 19112761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profile of acne patients in the Philippines requiring a second course of oral isotretinoin.
    Haryati I; Jacinto SS
    Int J Dermatol; 2005 Dec; 44(12):999-1001. PubMed ID: 16409263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.